{
    "id": 25848,
    "fullName": "FGF9 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "FGF9 over exp indicates an over expression of the Fgf9 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2254,
        "geneSymbol": "FGF9",
        "terms": [
            "FGF9",
            "FGF-9",
            "GAF",
            "HBFG-9",
            "HBGF-9",
            "SYNS3"
        ]
    },
    "variant": "over exp",
    "createDate": "01/03/2017",
    "updateDate": "01/03/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9670,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, gastric cancer cell lines over expressing FGFR3 and FGF9, and resistant to Herceptin (trastuzumab), demonstrated sensitivity to AZD4547 in culture, resulting in decreased cell growth (PMID: 27267856).",
            "molecularProfile": {
                "id": 26963,
                "profileName": "FGF9 over exp FGFR3 over exp"
            },
            "therapy": {
                "id": 654,
                "therapyName": "AZD4547",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7462,
                    "pubMedId": 27267856,
                    "title": "An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27267856"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9671,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Dovitinib (TKI258) resulted in inhibition of cell migration and decreased phosphorylation of Akt in a Herceptin (trastuzumab) resistant gastric cancer cell line over expressing FGFR3 and FGF9 in culture, and decreased tumor volume in xenograft models (PMID: 27267856).",
            "molecularProfile": {
                "id": 26963,
                "profileName": "FGF9 over exp FGFR3 over exp"
            },
            "therapy": {
                "id": 721,
                "therapyName": "Dovitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7462,
                    "pubMedId": 27267856,
                    "title": "An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27267856"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26962,
            "profileName": "FGF9 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26963,
            "profileName": "FGF9 over exp FGFR3 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}